Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2003
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002028430A3 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2001085147A3 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162801 Tricyclic compounds and their uses
08/28/2003US20030162798 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162716 Methods useful in the treatment of bone resorption diseases
08/28/2003US20030162714 Modulate cell differentiation; muscular disorders; fat metabolism; bone disorders
08/28/2003US20030162300 Galactomannan-oligosaccharides and methods for the production and use thereof
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161884 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/28/2003US20030161878 Pharmaceutical pills having storage stability formed by mixing alendronic acid and/or sodium salts, binders, lubricants and diluents, used for prophylaxis of bone disorders such as osteoporosis
08/28/2003US20030161863 Administering mixtures of nutrients for prophylaxis of muscular, metabolic or respiratory disorders, injuries, inflammation and/or to relieve stress
08/28/2003US20030161858 Mixtures of cement powders, vitamins, hormones, antibiotics, antitumor agents, somatotropins, calcium phosphates or proteins dissolved, dispersed or emulsified in oils; bone disorders
08/28/2003US20030161819 Genetic engineering; promoters; deactivation of major histocompatibility complex
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476679A1 Vitamin d3 derivatives and remedies using the same
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476438A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/28/2003CA2456444A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina)
08/27/2003EP1337639A2 Master bone formation transcription factor: compositions and methods of use
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337526A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/27/2003EP1337521A1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337272A2 Combination of gaba agonists and aldose reductase inhibitors
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337268A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1143920B1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
08/27/2003EP1140938B1 High affinity inhibitors for target validation and uses thereof
08/27/2003EP1140889B1 Compounds and methods for modulation of estrogen receptors
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0942740B1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438998A Quinolinyl and benzothiazolyc PPAR-gamma modulators
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438893A Therapeutical use of sophora flavescens or sophora subprostrated extracts
08/27/2003CN1438892A Low carbony drate compositions, kits thereof, and methods of use
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/27/2003CN1438244A Self-body immunity-disease related egg-yolk atibody preparation method and use thereof
08/27/2003CN1438028A Plaster for treating lumbar vertebra osteoproliferation
08/27/2003CN1438025A Medicine for treating protrasion of the lumbar intervertebral and preparation method
08/27/2003CN1438021A Ointment for bone-setting due to trauma and preparation method
08/27/2003CN1438006A medicine for treating orthopedic disease
08/27/2003CN1437998A Oral liquor for treating rheumatism
08/27/2003CN1437997A Internal organs toxicant-eliminating pill and preparation method
08/27/2003CN1437992A Blackbone-chicken setting-bone paste
08/27/2003CN1437984A Medicine for treating osteoporosis
08/27/2003CN1437976A Gukang capsule (for bone) and its production process
08/27/2003CN1437966A Oil-bone-setting method
08/27/2003CN1437958A Medicated food for treating rheumarthritis and preparation method thereof
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119313C Inhibition of matrix metallo proteases by 2-(omega-aroylalkyc)-4-biaryl-oxobutyric acids
08/27/2003CN1119156C Xiancaoteng capsule made korean epimedium herb, liquorice root and common threewingnut root and its preparation
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610829 Human extracellular matrix-1
08/26/2003US6610826 Cyclopeptide derivatives with integrin inhibitor properties
08/26/2003US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases
08/26/2003US6610750 Rhein or an ester
08/26/2003US6610745 Use of 2-hydroxy-4-trifluoromethyl-benzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-KS
08/26/2003US6610737 Non-psychotropic cannabinoids
1 ... 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 ... 820